deferiprone has been researched along with Chronic Kidney Failure in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kontoghiorghes, GJ | 1 |
| Barr, J | 1 |
| Baillod, RA | 1 |
| Canteros-Piccotto, MA | 1 |
| Fernández-Martín, JL | 1 |
| Cannata-Ortiz, MJ | 1 |
| Cannata-Andía, JB | 1 |
2 other studies available for deferiprone and Chronic Kidney Failure
| Article | Year |
|---|---|
Studies of aluminium mobilization in renal dialysis patients using the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
Topics: Adult; Aged; Aluminum; Chromatography, High Pressure Liquid; Deferiprone; Female; Humans; Iron; Iron | 1994 |
Effectiveness of deferiprone (L1) releasing the aluminum bound to plasma proteins in chronic renal failure.
Topics: Aluminum; Blood Proteins; Chelating Agents; Deferiprone; Humans; In Vitro Techniques; Kidney Failure | 1996 |